1. Home
  2. CODA vs NVNO Comparison

CODA vs NVNO Comparison

Compare CODA & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CODA
  • NVNO
  • Stock Information
  • Founded
  • CODA 1994
  • NVNO 1987
  • Country
  • CODA United States
  • NVNO United States
  • Employees
  • CODA N/A
  • NVNO N/A
  • Industry
  • CODA Industrial Machinery/Components
  • NVNO Medical/Dental Instruments
  • Sector
  • CODA Industrials
  • NVNO Health Care
  • Exchange
  • CODA Nasdaq
  • NVNO Nasdaq
  • Market Cap
  • CODA 83.5M
  • NVNO 96.0M
  • IPO Year
  • CODA N/A
  • NVNO N/A
  • Fundamental
  • Price
  • CODA $7.58
  • NVNO $1.00
  • Analyst Decision
  • CODA Strong Buy
  • NVNO
  • Analyst Count
  • CODA 1
  • NVNO 0
  • Target Price
  • CODA $11.00
  • NVNO N/A
  • AVG Volume (30 Days)
  • CODA 44.4K
  • NVNO 1.4M
  • Earning Date
  • CODA 09-15-2025
  • NVNO 07-31-2025
  • Dividend Yield
  • CODA N/A
  • NVNO N/A
  • EPS Growth
  • CODA 21.86
  • NVNO N/A
  • EPS
  • CODA 0.30
  • NVNO N/A
  • Revenue
  • CODA $22,758,966.00
  • NVNO N/A
  • Revenue This Year
  • CODA $30.82
  • NVNO N/A
  • Revenue Next Year
  • CODA $20.84
  • NVNO N/A
  • P/E Ratio
  • CODA $25.26
  • NVNO N/A
  • Revenue Growth
  • CODA 24.78
  • NVNO N/A
  • 52 Week Low
  • CODA $5.76
  • NVNO $0.90
  • 52 Week High
  • CODA $9.89
  • NVNO $5.70
  • Technical
  • Relative Strength Index (RSI)
  • CODA 50.30
  • NVNO 18.49
  • Support Level
  • CODA $7.01
  • NVNO $0.90
  • Resistance Level
  • CODA $7.86
  • NVNO $5.09
  • Average True Range (ATR)
  • CODA 0.36
  • NVNO 0.37
  • MACD
  • CODA -0.01
  • NVNO -0.46
  • Stochastic Oscillator
  • CODA 65.14
  • NVNO 2.36

About CODA Coda Octopus Group Inc. Common stock

Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: